Skip to content
healthcare.dev

CLORAZEPATE DIPOTASSIUM

NDC 13107-283, CLORAZEPATE DIPOTASSIUM, tablet, from Aurolife Pharma LLC.

Product NDC
13107-283
Status
Listed
Labeler
Aurolife Pharma LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA071858
DEA schedule
CIV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13107-283 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CLORAZEPATE DIPOTASSIUM7.5 mg/1

Pharmacologic classes

Benzodiazepine [EPC]; Benzodiazepines [CS]

Package NDCNDC-11Package
13107-283-0113107028301100 TABLET in 1 BOTTLE, PLASTIC (13107-283-01)
13107-283-0513107028305500 TABLET in 1 BOTTLE, PLASTIC (13107-283-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/69451c35-dd9a-4690-8d5e-4dcfa8837620
  • NADAC price for package 13107028301

    GET /v1/drugs/nadac/13107028301
  • NADAC price for package 13107028305

    GET /v1/drugs/nadac/13107028305

Use it

Look up 13107-283 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13107-283 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13107-283. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.